Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) Return on Sales (2022 - 2025)

Neuraxis' Return on Sales history spans 4 years, with the latest figure at 2.62% for Q3 2025.

  • For Q3 2025, Return on Sales fell 13.0% year-over-year to 2.62%; the TTM value through Sep 2025 reached 2.09%, up 99.0%, while the annual FY2024 figure was 2.67%, 5.0% up from the prior year.
  • Return on Sales for Q3 2025 was 2.62% at Neuraxis, down from 1.94% in the prior quarter.
  • Across five years, Return on Sales topped out at 12.94% in Q3 2022 and bottomed at 6.33% in Q3 2023.
  • The 4-year median for Return on Sales is 2.4% (2023), against an average of 1.46%.
  • The largest annual shift saw Return on Sales plummeted -1927bps in 2023 before it surged 384bps in 2024.
  • A 4-year view of Return on Sales shows it stood at 1.61% in 2022, then tumbled by -49bps to 2.4% in 2023, then soared by 52bps to 1.16% in 2024, then plummeted by -126bps to 2.62% in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Return on Sales are 2.62% (Q3 2025), 1.94% (Q2 2025), and 2.56% (Q1 2025).